All News & Research Articles

Alzheimer's Disease Research

New BrightFocus-funded research explores how a protein called tau, critical to Alzheimer’s, turns from normal to a diseased state. This discovery presents a new target to potentially prevent or treat Alzheimer's disease.

Sep 22, 2022
Alzheimer's Disease Research

Eye-brain research is revealing that the APOE4 mutation has a much different impact in glaucoma than in Alzheimer’s, a discovery that may lead to a new glaucoma treatment.

Sep 19, 2022
Macular Degeneration Research

A team including two BrightFocus grantees has successfully transplanted a patch of retinal tissue into a patient with geographic atrophy. This experimental therapy was part of an NIH clinical trial and marks the first time in the U.S. that stem cells derived from a patient’s own tissue have been used to replace eye cells. 

Sep 14, 2022
Macular Degeneration Research

A new oral pill for geographic atrophy is being tested in an early-stage clinical trial.

Aug 11, 2022
Research News

Donald Weaver’s $1 million BrightFocus Centennial grant helped lead to his new exploration of Alzheimer’s roots, which he and colleagues have proposed may lie with an out-of-control autoimmune reaction. 

Aug 5, 2022
Macular Degeneration Research
Jun 28, 2022
Research News

Recently, when their groundbreaking genetics discovery was featured on the cover of Nature, the research team thanked BrightFocus for critical early funding that supported their accomplishments.

Apr 13, 2021
Press Releases

Press release on a new Alzheimer’s drug which shows promising results to slow disease progression.

Mar 11, 2021
Diet & Nutrition
Recent BrightFocus grantee Sheldon Rowan tells how the Mediterranean diet, the microbiome, and other factors come together in a solid defense against AMD.
Oct 7, 2020